original contributions nature publishing group In addition to its debated effect on blood pressure, chronic variation of sodium intake has been reported to modulate the cardiovascular morphology in rats 1 and humans. 2 The influence of sodium diet has been extensively assessed in hypertensive rats [3] [4] [5] [6] [7] but less is known in normotensive rats. To mimic the human situation, we developed a model of early and excessive sodium chloride consumption in normotensive rats using an 8% NaCl diet proposed from weaning to the age of 5 months. Using this model, we have previously reported that left ventricular (LV) hypertrophy developed without detectable fibrosis and despite no consistent increase in arterial pressure, 1 thus suggesting that other hemodynamic and/or nonhemodynamic factors are involved.
In addition to its debated effect on blood pressure, chronic variation of sodium intake has been reported to modulate the cardiovascular morphology in rats 1 and humans. 2 The influence of sodium diet has been extensively assessed in hypertensive rats [3] [4] [5] [6] [7] but less is known in normotensive rats. To mimic the human situation, we developed a model of early and excessive sodium chloride consumption in normotensive rats using an 8% NaCl diet proposed from weaning to the age of 5 months. Using this model, we have previously reported that left ventricular (LV) hypertrophy developed without detectable fibrosis and despite no consistent increase in arterial pressure, 1 thus suggesting that other hemodynamic and/or nonhemodynamic factors are involved.
Beside an increase in cardiac postload, high sodium intake may indirectly affect cardiac geometry through various factors including hemodynamic changes such as an increase in circulating volume 8 and a decrease distensibility of large arteries. 9 For instance, in uninephrectomized, deoxycorticosterone acetate rats, volume expansion was only observed when a high-sodium diet was proposed 10 and cardiac hypertrophy in this situation of increased preload was characterized by an augmented length and diameter of cardiomyocyte. 11 Aortic stiffness and pulse pressure (PP) may also participate in the deleterious effect of sodium on the heart. Independently of mean arterial pressure, high salt consumption strongly correlates with aortic rigidity in humans 9, 12 as well as in hypertensive rats with structural and functional changes of large arteries. 8 Increased aortic impedance may in turn lead to LV hypertrophy with moderate interstitial fibrosis. 13 Yet, sodium-induced cardiac hypertrophy also occurs without change in blood volume and pressure in normotensive uninephrectomized rats. 14 In response to high sodium intake, endothelin-1 (ET-1) rose in the urine of intact rats 15 and in plasma of rats with deoxycorticosterone acetate-salt hypertension with a beneficial effect of combined ETA-ETB receptor blockade with bosentan on LV hypertrophy. 10 Therefore,
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Volume and High-Salt Cardiac Hypertrophy despite the lack of fibrosis observed in early and long-time high sodium-feeding rats, 1 endothelin could play a role in the development of cardiac hypertrophy.
The present study tested the first hypothesis that cardiac hypertrophy associated with long-term (since weaning) high salt feeding was related to enhanced plasma volume or arterial stiffness. A specific objective was to further characterize structure and function of the heart using Doppler-echocardiography determination and measurement of cardiomyocyte size. In addition, involvement of endothelin in the hemodynamic and cardiac consequences of high-sodium diet was evaluated through pharmacological blockade of endothelin receptors with bosentan.
Methods
The present animal experiments complied with the European and French laws (permit numbers B-3417226 and 34179) and conform to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (publication no. 85-23, revised 1996).
Forty male Sprague-Dawley rats were fed regular sodium (NS, 0.64% NaCl, n = 16) or high sodium (HS, 8% NaCl, n = 24) diet, since weaning. At the age of 5 months, a group of eight rats fed HS diet received the nonselective ET A -ET B endothelin receptor antagonist bosentan for 14 days. Bosentan was given by gavage at the daily dose of 30 mg/kg, as previously described. 16 In preliminary experiments, such a dose of bosentan given for 3 days totally blocked the vasopressor and vasodepressor responses to an intravenous bolus of ET-1 (300 pmol/kg). Echocardiographic measurements and plasma volume were assessed in the bosentan-treated HS rats as well as in untreated eight NS and eight HS rats. Pulse wave velocity (PWV) was determined in the remaining untreated NS and HS rats (n = 8 in each).
Doppler echocardiography. Two days before the end of treatment period, Doppler-echocardiography (MyLab 30; Esaote, Genoa, Italy) was performed in anesthetized (ketamine and xylazine, 75 and 25 mg/kg) rats as described previously. 17 Anterior (AWT), posterior (PWT) wall thicknesses were measured and LV mass was estimated by using the standard cube formula. Determination of LV end diameters in diastole (LVEDd) and in systole allowed calculation of endocardial shortening fraction. Diastolic relative wall thickness was calculated as ((AWTd + PWTd)/LVEDd) × 100 and was used as an index of LV geometry. Ascending aortic blood flow was recorded, as previously described 18 via pulsed-wave Doppler permitting measurements of the aortic blood flow velocity time integrals (VTI Ao ). Peak velocities of early diastolic rapid inflow (peak E), atrial contraction filling (peak A), as well as their ratio (E/A) were recorded and served as indexes of diastolic function. LV subendocardial (ENDO) and subepicardial (EPI) anterior and posterior wall velocities were measured offline at the level of the papillary muscles by tissue Doppler imaging.
Hemodynamic parameters. At the end of treatment period, rats were anesthetized with pentobarbital sodium (60 mg/ kg body weight intraperitoneal). A polyethylene catheter (PE-50) was inserted into the right jugular vein for blood sampling and dye injection. Another PE-50 catheter was inserted into the LV via the right carotid artery. The maximal rate of increase in LV pressure (+dP/dt max ), the LV systolic and LV end-diastolic pressures were measured. Then, the arterial catheter was pulled back into the carotid artery for arterial pressure and heart rate recording for 30 min.
Estimation of plasma volume. After stabilization of arterial pressure and heart rate, blood was sampled for determination of hematocrit, plasma protein (refractometry), and endothelin concentration. Then, plasma volume was estimated by a bolus injection of Evans blue (5 mg/kg intravenous) as previously described. 19 Five min later, blood was sampled for plasma Evans blue concentration determination by spectrophotometry at 620 nm. Plasma and blood volume were calculated and expressed as ml/kg body weight.
Plasma and myocardial ET-1 levels. Plasma and myocardial ET-1 levels were measured by ELISA kit (Assay Designs, Ann Arbor, MI). Briefly, precoated wells were treated with 100 µl of plasma or LV tissue homogenate sample and incubated overnight at +4 °C. Then, plates were incubated with monoclonal antibody directed against ET-1, followed by horseradish peroxidase-conjugated antibody. Plates were read by spectrophotometry at 450 nm.
Aortic blood pressure and PWV. In two separate groups of eight untreated rats fed NS or HS diet, catheters were introduced into the descending thoracic and abdominal aorta for measurement of central and peripheral blood pressures for 30 min. An algorithm calculated mean pressure (waveform area) and thoracoabdominal pulse wave transit time (highest correlation between the two pressure waveforms). PWV was calculated as the distance between the two cannula tips divided by the pulse wave transit time. 20 Tissue weighing and cardiomyocyte size measurement. The heart, the right ventricle and LV were weighed, and ratios to body weight were calculated as indexes of cardiac (HWI) and LV (LVWI) hypertrophy.
Paraffin embedded LV was cut (5 µm slices) and stained with hematoxylin-eosin. To determine the cardiomyocyte size, the shortest transverse diameter was measured in 30 transverse sections per heart. LV and thoracic aorta geometry and composition. Calcification of the elastic fiber network is an important determinant of aortic wall stiffness 21 and myocardial calcification has frequently been reported in cardiac hypertrophy associated with chronic renal failure. 22 After dehydration, the percentage of dry weight and total calcium content (atomic absorption spectrophotometry) of 150 mg of the apex of the ventricle and 1 cm of the descending thoracic aorta was determined as previously described. 20 Another LV fragment served for measurement of protein and collagen content.
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The internal (D i ), external diameter (D e ), medial cross-sectional area and medial thickness (h) of the first cm of descending aorta were measured on 20-µm thick sections stained with hematoxylin-eosin. 20 Elastic modulus (EM = PWV 2 . D i . ρ/h, Moens-Korteweg) and wall stress (WS = central aortic mean blood pressure. D i /2 h, Lamé) were calculated with ρ = blood density, 1.05 g·cm −3 . EM/WS was used as an isobaric index of intrinsic aortic wall stiffness. 20 Protein and collagen contents were determined on the third cm of the descending aorta after HCl hydrolysis.
Statistical analysis. Data (mean ± s.e.m.) were analyzed by one-way analysis of variance. Between groups differences were determined using the Fisher's protected least significant difference test for multiple comparisons. The level of significant difference was set for P < 0.05.
results influence of hs diet on cardiac and aortic hemodynamic and morphology
As reported in Figure 1 , long-term high sodium feeding was associated with a slight and significant elevation in both femoral and aortic arterial pressure and heart rate measured in anesthetized rats. Body weight was similar in HS and NS untreated groups whereas heart weight and LV weight were higher in HS rats ( Table 1) . Heart weight index was significantly (P < 0.0001) augmented in the later group compared to NS control group (HWI of 3.15 ± 0.06 vs. 2.60 ± 0.08 mg HW/g BW, respectively). In addition, diameter and crosssectional area of LV cardiomyocyte were markedly augmented in HS rats (Figure 2) . Aortic wall thickness and medial crosssectional area were increased in the HS compared to NS group ( Table 1) . As shown in Figure 1 , aortic mean arterial pressure significantly and positively correlates with HWI (r = 0.80, P = 0.0006) and aortic wall thickness (r = 0.76, P = 0.0005).
LV pressures were unaffected by the HS diet while +dP/dt max and central venous pressure were higher in rats exposed to the HS diet.
influence of hs diet on aortic stiffness and collagen content of aorta and lV Aortic PP was higher in rats fed HS diet than in control rats (35 ± 1 vs. 30 ± 1 mm Hg, respectively, P = 0.02) but the ratio aortic PP to aortic mean arterial pressure was similar in both groups ( Table 1) . Thoracoabdominal PWV and the ratio of elastic modulus to wall stress were similar in both diet groups ( Table 1) . Collagen and calcium content of LV was not influenced by salt intake and calcium content of aortic wall was slightly increased in the HS diet group ( Table 2) .
influence of hs diet on echocardiographic parameters
As reported in Table 3 and exemplified with M-mode tracings in Figure 3 , untreated HS rats presented, when compared to NS rats, LV hypertrophic remodeling characterized by no change in LV diameters (systolic and diastolic) and marked increase in PWT and AWT. These results were therefore related to a marked increase of the relative wall thickness in HS compared to NS rats (Figure 3) . It is however of note that no alteration of the global and regional (velocities of ENDO and EPI layers) systolic and diastolic (E/A ratio) function was detected in untreated HS when compared to NS rats ( Table 3) .
influence of hs diet on et-1 and plasma volume
As presented in Table 1 , plasma level of ET-1 was twofold higher in untreated HS than in NS diet fed rats. However, ET-1 level in LV tissue was similar in both groups. As depicted on Figure 4 , plasma volume was increased by 54% in untreated HS rats compared with NS rats (58 ± 7 vs. 37 ± 2 ml/kg, P < 0.05) without significant variation in hematocrit or plasma protein concentration ( Table 3) .
influence of chronic treatment with bosentan in high-sodium diet fed rats Treatment for 14 days by bosentan had no detectable influence on blood pressure in rats fed the HS diet ( Table 3) . Heart weight index and LV Evans blue space were not significantly different in bosentan-treated as compared with untreated HS rats. In addition, regarding LV geometry, and LV global and regional function, no marked effect of bosentan was detected by Doppler-echocardiography between treated and untreated HS rats ( Table 3) . The augmented plasma volume observed in untreated HS group was not modified by bosentan (Figure 4) .
discussion
The present results confirm our previous report 1 and demonstrate that sodium-induced cardiac hypertrophy is of concentric pattern as suggested by the increase in cardio- myocyte size and the higher relative wall thickness. In addition, cardiac hypertrophy was observed without enhancement in cardiac collagen content as measured in the present study, a finding that corroborates the lack of cardiac fibrosis previously reported. 1 Interestingly, sodium-induced morphological change of the heart was not accompanied by detectable alterations of the conventional parameters of systolic function such as LV shortening fraction and dP/dt max . Regional myocardial function equated with endocardial and epicardial velocities obtained by tissue Doppler imaging was similar in the two sodium diet groups. At variance, a decreased compliance and LV diastolic dysfunction was observed together with an abnormal accumulation of fibrillar collagen in human and rat models of hypertension-induced LV hypertrophy. 23 Although cardiac alterations could appear after a longer exposure to high sodium feeding or when associated with a clear increase in blood pressure, 24 we cannot exclude that compensatory mechanisms, which have to be explored, may occur and protect the heart in our particular model of early and long-term feeding with high-sodium diet. Beside its absolute level, arterial pressure may participate in cardiac hypertrophy through an increase in PP. Specific measurement of PP in the present study indicates that it was enhanced in rats fed high-sodium diet. Because the ratio of PP to aortic mean arterial pressure was similar in both diet groups, the elevated PP was likely related to the increase in aortic mean arterial pressure in high-sodium fed rats. Although it was not measured in the present study, increased arterial pressure variability may also participate in the cardiovascular alterations associated with high sodium intake. Of note, heart weight index and aortic thickness were positively correlated with aortic arterial pressure, thus suggesting that blood pressure plays a role in the sodium-induced cardiovascular hypertrophy despite its slight increase. Using a less severe high-sodium diet (2% for five or 3-6 months), we 1 and others 25 were unable to dissociate the effect of high-sodium diet on blood pressure and cardiac mass. These findings suggest that a large amount of sodium, an increase in arterial pressure, even slight, or both are required for the pro-hypertrophic cardiac and vascular effect of high dietary sodium. As observed in the heart, vascular hypertrophy was associated with no change in collagen content of the aortic wall. In addition, intrinsic aortic wall stiffness evaluated by PWV and elastic modulus was not altered by high sodium feeding, and only a weak increase in calcium was found in the present study. This is at variance with data obtained in genetic models of hypertension. In Dahl salt-sensitive, 26 stroke-prone hypertensive 7 and spontaneously hypertensive rats, 27,28 excessive sodium intake was associated with vascular wall thickening and increased collagen content. The results obtained in humans 29 and rats 30 at the site of carotid artery indicate that arterial wall hypertrophy may not necessarily be associated with reduced compliance when hypertensive and normotensive subjects or rats are compared for a given blood pressure level. The mechanism explaining the lack of increase in elastic modulus remains purely speculative. 31 In our model of early and long-term feeding with a HS, it seems that. Whether the lack of influence of excessive sodium consumption on aortic compliance observed in our model is related to the enhanced vascular response to nitric oxide previously reported 32 remains to be determined. 
NS HS HS+bosentan
Experimental parameters
Mean arterial pressure, mm Hg 129 ± 5 131 ± 11 126 ± 10
Heart rate, beats/min 316 ± 13 361 ± 17 378 ± 17
Final BW, g 523 ± 10 523 ± 0 528 ± 9
Heart weight index, mg/g 2.84 ± 0.05 3.18 ± 0.10* 3.01 ± 0.06
Echocardiographic parameters
Left ventricular end-diastolic diameter, mm In the absence of major changes in arterial pressure, volume overload may participate in the cardiac hypertrophy. 8 A twofold higher plasma volume was observed in the present rats fed the high-sodium diet. The increase in circulating volume may be partly related to the decrease in glomerular filtration rate, and subsequent renal fluid retention, previously reported in this model. 1, 33 The lack of significant changes in hematocrit and plasma protein concentration suggests that a new steady state of circulating volume was reached before the end of the study in our model. In addition, the higher central venous pressure measured in HS fed rats suggests that the heart very likely faced a chronic increase in venous return and preload. Although cardiac remodeling results from complex interactions between pressure and volume overload, eccentric hypertrophy is usually associated with volume overload. 8 Despite the concentric pattern of cardiac hypertrophy and the lack of correlation with plasma volume, a role of an increased circulating volume, per se or through subtle changes in blood pressure, cannot be ruled out in the development of cardiac hypertrophy at the onset of high sodium feeding.
Beside pressure and volume overload, nonhemodynamic factors may participate in the salt-induced cardiovascular alterations. We have previously reported that aldosterone but not oxidative stress is involved in the salt-associated alterations; 1 yet, chronic suppression of free radicals production or angiotensin II generation would give additional information. In the current experiments, the effect of chronic blockade of endothelin was assessed because high sodium feeding is often associated with an increase in endothelin production in normotensive rats 15 and in sodium-sensitive forms of hypertension. [34] [35] [36] In the present model, plasma but not cardiac tissue level of ET-1 was elevated in high-sodium diet fed rats, as reported in rats with aortic valve regurgitation. 37 The lack of cardiac fibrosis and the inefficiency of bosentan observed in the present high sodium fed rats may be partly explained by the absence of increase in cardiac ET-1 level. Similarly, bosentan was devoid of beneficial influence in a model of malignant hypertension 38 and in deoxycorticosterone acetate-salt hypertension despite a reduction in blood pressure. 35 Interestingly, a salt-sensitive hypertension was obtained in rats chronically treated with a specific ET B receptor blocker 15 and in endothelin-B receptor-deficient rats, 39 indicating a major role of ET B receptor in the control of arterial pressure. It is therefore plausible that concomitant blockade of ETB by bosentan may mask a beneficial influence of ETA receptor antagonism in our model. Without excluding that a longer administration of a higher dose of bosentan might have a more pronounced effect, specific blockade of ETA receptor could also be useful to reveal a beneficial influence of ETB receptor in the situation of chronic and long-term high sodium consumption. original contributions
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In conclusion, the present work provides further evidence for a cardiovascular hypertrophic influence of long-term, high sodium intake. Despite the increase in plasma volume and probably, in cardiac preload, cardiac hypertrophy is of concentric pattern. Aortic rigidity and endothelin do not seem to participate in cardiovascular alterations induced by the high-sodium diet. The absence of cardiac fibrosis reported in our model 1 is in agreement with the present lack of change in collagen content of the heart as well as with the unaffected cardiac systolic and diastolic function determined after 5 months on HS. One cannot exclude that cardiac dysfunction may require a longer duration of high salt feeding to take place or that it might be unmasked by additional chronic or acute stress, particularly resulting from endothelial dysfunction. Another explanation for the "isolated" cardiac hypertrophy is an early cardiovascular adaptation when highsodium diet was proposed immediately after weaning, a situation at variance with others. Changes in arterial pressure and circulating volume, together with a possible direct effect of sodium ion, are probably major determinants of the morphologic influence of chronic high sodium consumption on the cardiovascular system. Additional investigation is needed to deepen the mechanism implicated in the direct effect of sodium on target organ damage. 
